title: FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms.
authors.affiliation: Aventis, Frankfurt, Germany. martin.siewert@aventis.com
authors.forename: Martin
authors.initials: M
authors.lastname: Siewert
authors.forename: Jennifer
authors.initials: J
authors.lastname: Dressman
authors.forename: Cynthia K
authors.initials: CK
authors.lastname: Brown
authors.forename: Vinod P
authors.initials: VP
authors.lastname: Shah
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D000287:Administration, Topical; D002214:Capsules; D004304:Dosage Forms; D004339:Drug Compounding; D004345:Drug Industry / Q000379:methods*; D007263:Infusions, Parenteral; D013488:Suppositories; D013535:Suspensions; D013607:Tablets
chemical_list: D002214:Capsules; D004304:Dosage Forms; D013488:Suppositories; D013535:Suspensions; D013607:Tablets